Example: Heart Attack

Search clinical trials for: Dose decrease

Total 7790 results

NCT04966325

Completed

Thorough QT (TQT) Study to Evaluate the Effect of LC350189 on Cardiac Repolarization in Healthy Male and Female Subjects

Hyperuricemia | Gout | Qt Interval, Variation in
NCT00790907

Completed

Fondaparinux Trial With Unfractionated Heparin (UFH) During Revascularization in Acute Coronary Syndromes (ACS) (FUTURA/OASIS 8)

Acute Coronary Syndrome
NCT02170740

Completed

Assessment of Safety, Pharmacokinetics and the Effect of BIBR 1048 MS on Coagulation Parameters in Healthy Volunteer Subjects

Healthy
NCT00811421

Completed

Evaluation of Alternative Antimalarial Drugs for Malaria in Pregnancy (MiPPAD)

HIV Infections | Pregnancy | Malaria
NCT00617643

Completed

Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis

HIV Infections | Tuberculosis
NCT02245438

Terminated

Effect of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Norethindrone-Ethinyl Estradiol in Healthy Female Adult Volunteers

Healthy
NCT07590310

Recruiting

Clinical Application of CAIX-Targeted PET Imaging in Tumors

Kidney Cancers
NCT07057778

Not yet recruiting

Iguratimod Plus Low-dose Rituximab vs Low-dose Rituximab in Corticosteroid-resistant or Relapsed ITP

Immune Thrombocytopenia (ITP)
NCT06951971

Not yet recruiting

Dose-modified Emapalumab and Ruxolitinib (E-Ru) Regimens for Hemophagocytic Lymphohistiocytosis

Hemophagocytic Lymphohistiocytosis (HLH)
NCT04523896

Recruiting

HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate Cancer (BRAchySABR)

Prostatic Neoplasm
NCT01687647

Terminated

Sputum Cytometry Analysis in Lung Cancer Screening After Professional Asbestos Exposure (AMORCE-CBP)

Lung Neoplasms
NCT02800551

Completed

Clinical Trial Comparing Dose-intensified SBRT With Conventional Radiation Therapy for Spinal Metastases (DOSIS RCT)

Spinal Metastasis
NCT05840289

Active, not recruiting

A Study on Fractionated Rituximab to Avoid Lysis Syndrome in Aggressive B-Lymphoma (FRILLY)

Aggressive B-Cell Non-Hodgkin Lymphoma
NCT05468294

Active, not recruiting

F16IL2 in Combination With Nivolumab in Patients With Non-small Cell Lung Cancer (Nivokin)

Non-small Cell Lung Cancer (NSCLC)
NCT02858180

Completed

Hepatitis C Virus(HCV) Heart and Lung Study

Heart Failure | Pulmonary Disease, Chronic Obstructive | Hepatitis C, Chronic | Lung Diseases, Interstitial
NCT03700229

Unknown

Study to Evaluate Rituximab and Bortezomib in Patients With Newly Diagnosed Acquired Hemophilia A

Acquired Hemophilia A
NCT00827021

Completed

The Clinical Evaluation of the Dose of Erythropoietins Trial (CEDOSE)

Kidney Failure, Chronic
NCT01684163

Completed

Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants

Major Depressive Disorder
NCT02233907

Completed

Post-marketing Surveillance of Ventilat® in Long-term Therapy in Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive
NCT02859129

Completed

Study to Evaluate the 2-Way Interaction Between Multiple Doses of Epanova™ and a Single Dose of Rosuvastatin (Crestor®) (ECLIPSEIII)

Hypertriglyceridemia
NCT06788340

Not yet recruiting

MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease (MOVE-IT)

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis
NCT05135442

Not yet recruiting

Efficacy and Safety of Bortezomib as First-line Treatment of Acquired TTP

Thrombotic Thrombocytopenic Purpura, Acquired
NCT06101238

Completed

BLOODSAFE Ghana- Iron and Nutritional Counselling Strategy (UH3BLIS)

Blood Donation
NCT06095375

Completed

Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients (REGOMA-2)

Glioblastoma, IDH-wildtype | MGMT-Methylated Glioblastoma
NCT04474470

Completed

A Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer

Head and Neck Cancer | Squamous Cell Carcinoma of Head and Neck | Metastatic Solid Tumor | Colorectal Adenocarcinoma | Solid Tumor, Adult | Recurrent Solid Tumor
NCT04815694

Unknown

THeragnostic Utilities for Neoplastic DisEases of the Rectum by MRI Guided Radiotherapy (THUNDER2)

Locally Advanced Rectal Cancer | Pathological Complete Response | Neoadjuvant Chemoradiotherapy
NCT02936037

Terminated

Effect of MD1003 in Progressive Multiple Sclerosis (SPI2) (SPI2)

Multiple Sclerosis
NCT01251536

Completed

Cetuximab Standard or Dose Escalation in First Line Colorectal Cancer (Everest2)

Colorectal Cancer
NCT02777125

Completed

A Randomized Trial Comparing Metered Dose Inhalers and Breath Actuated Nebulizers

Asthma
NCT03045510

Unknown

Efficacy and Safety of Ultra Small Dose Decitabine for the Lower Risk MDS Patients With Transfusion Dependent

Myelodysplastic Syndromes
NCT01412827

Completed

Accuracy of Half of the Usual Radiotracer Dose in SPECT (SPECT-Light)

Coronary Artery Disease
NCT00586014

Completed

High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma

Multiple Myeloma
NCT01212263

Completed

Clomiphene Citrate (CC) Co-treatment With HP Urinary FSH vs HP Urinary FSH in CC-resistant PCOS

Polycystic Ovary Syndrome
NCT01333332

Unknown

Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas Cancer

Pancreatic Cancer
NCT00037206

Completed

A Safety & Effectiveness Study of Intravenous Anidulafungin With AmBisome® for Treatment of Invasive Aspergillosis (IA).

Aspergillosis
NCT00262015

Unknown

Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine

Meningococcal Disease; Meningococcal Meningitis
NCT00755599

Withdrawn

Eisenhower's Alternative Speculum Examination (EASE)

Papanicolaou Smear
NCT04334590

Withdrawn

Fabrication of Sequential Naso-Alveolar Molding Appliances in the Treatment of Cleft Lip/Nose Deformities

Cleft Lip | Nose Deformities, Acquired | Deformity | Congenital Nose Malformation
NCT02693067

Active, not recruiting

A Phase 1 Study of PV-10 Chemoablation of Neuroendocrine Tumours (NET) Metastatic to the Liver

Neuroendocrine Tumors Metastatic to the Liver
NCT04289272

Completed

Evaluating Dove Confident Me in India

Body Image
NCT01631162

Unknown

The Identification of Different Lung Diseases by Analysis of Volatile Organic Compounds in Breath Samples (PHNOSE)

Asthma | Chronic Obstructive Lung Disease
NCT07512076

Not yet recruiting

A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer

Elderly Patients | Pharmacokinetic Study | Prostate Cancer Patients
NCT07140211

Recruiting

Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum Thrombosis (SHINE)

Venous Thromboembolism (VTE) | Postpartum
NCT06045481

Not yet recruiting

Postexposure Prophylaxis With Single Dose Doxycycline for the Prevention of Tick-borne Relapsing Fever

Relapsing Fever, Tick-Borne
NCT05827770

Not yet recruiting

The Efficacy and Safety of Neoadjuvant Toripalimab Combined With Temozolomide in Resectable Stage III Melanoma

Melanoma Stage III
NCT06795659

Completed

Combining Esketamine and Prolonged Exposure Treatment for PTSD (Post Traumatic Stress Disorder)

Post Traumatic Stress Disorder PTSD
NCT07061431

Completed

In Vitro and in Vivo Evaluation of the Anti-Inflammatory and Antithrombotic Synergy of Vitamin C and Bioflavonoids in Healthy Subjects (VCF)

Cardio-protection
NCT06050291

Completed

Investigating the Effect of Food on the Bioavailability of a Fixed Dose Combination of Obicetrapib and Ezetimibe

Healthy Volunteer Study
NCT04030052

Withdrawn

Emicizumab PUPs and Nuwiq ITI Study

Hemophilia A
NCT02105662

Completed

An Efficacy and Safety Study of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in the Treatment of Chronic Hepatitis C Virus in Participants Who Are Co-Infected With Human Immunodeficiency Virus:C-EDGE CO-INFXN (MK-5172-061)

Chronic Hepatitis C

Search clinical trials for: Dose decrease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations